Peer-influenced content. Sources you trust. No registration required. This is HCN.
MDLinx
Basal cell carcinoma, while common, rarely leads to death when detected and treated early. Physicians should be aware of the seven warning signs that can be mistaken for harmless skin conditions.
Dermatology July 29th 2024
Oncology News Central (ONC)
Infections account for over 50% of nonrelapse deaths in CAR T-cell therapy patients, outweighing therapy-specific toxicities like ICANS and CRS.
Hematology/Oncology July 29th 2024
The New England Journal of Medicine
MCED tests aim to detect multiple cancer types through a single blood test, potentially simplifying cancer screening and expanding detection capabilities. However, their implementation raises critical questions about evidence standards and evaluation methods.
PBMs’ vertical integration allows them to dictate cancer treatment decisions, from drug selection to delivery methods, potentially compromising patient care and increasing costs.
The 2024-2025 cancer care rankings incorporate outpatient outcomes and refine criteria for high-risk patient transfers, aiming to provide a more comprehensive evaluation of cancer care quality.
Experts note that the use of chemotherapy can indicate cancer spread beyond its origin, potentially reflecting the stage, aggressiveness, or progression potential of the disease.
Gastroenterology July 24th 2024